Two studies performed in cell lines from different cancer types (BC and CRC) showed that knockdown of SETD7 decreases Nrf-2, consequently decreasing its target genes and increasing ROS accumulation and apoptosis [44,77]. Here, NFE2L2 is linked to cancer.